tDCS + Speech Therapy for Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This study will investigate the effects of mild electrical stimulation in conjunction with speech therapy for people with post-stroke aphasia to enhance language recovery.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is tDCS safe for use in humans?
Research shows that transcranial direct current stimulation (tDCS) is generally safe for humans, with no serious adverse events reported in studies involving people with aphasia. It is a noninvasive brain stimulation method that has been safely combined with speech therapy over extended periods.12345
How does the tDCS + Speech Therapy treatment for aphasia differ from other treatments?
The tDCS + Speech Therapy treatment for aphasia is unique because it combines transcranial direct-current stimulation (tDCS), which uses a low-intensity electrical current to modulate brain activity, with traditional speech therapy. This combination aims to enhance the effectiveness of speech therapy by improving brain function and excitability, offering a promising approach for those with aphasia, especially when standard speech therapy alone has limited effectiveness.23567
What data supports the effectiveness of the treatment tDCS + Speech Therapy for Aphasia?
Research shows that transcranial direct-current stimulation (tDCS) combined with speech therapy can improve language abilities in people with aphasia after a stroke. Studies found that active tDCS led to greater language improvements compared to a placebo, and it was safely used over extended periods.23589
Who Is on the Research Team?
Sara Pillay, Ph.D
Principal Investigator
Medical College of Wisconsin
Are You a Good Fit for This Trial?
This trial is for adults who have language difficulties due to brain damage like a stroke. They must speak English fluently and be able to undergo an MRI scan. People with advanced neurodegenerative diseases, severe psychiatric conditions, uncorrectable hearing or vision issues, developmental disabilities, or contraindications to MRI are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive targeted or active-control anodal-tDCS with speech therapy for 10 therapy sessions
Crossover Treatment
Participants crossover to receive the alternative tDCS intervention within the same speech therapy arm
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Active Control Transcranial Direct Current Stimulation
- Targeted Transcranial Direct Current Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor